Josep Garre-Olmo

Nom:
Josep Garre-Olmo
Firma: Josep Garre-Olmo
Posició:
Responsable del Grup

Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer's disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients.

Measuring anticholinergic exposure in patients with dementia: A comparative study of nine anticholinergic risk scales.

What seems to matter in public policy and the health of informal caregivers? A cross-sectional study in 12 European countries.

Subscriure a Josep Garre-Olmo